IndraLab

Statements


CYLD inhibits JNK. 24 / 24
| 24

reach
"These results establish a pivotal role for CYLD in controlling Tak1 function and explain how CYLD negatively regulates IKKbeta and JNK."

reach
"Recent evidence demonstrates that CYLD negatively regulates the c-Jun N-terminal kinase (JNK) signaling pathway, a critical mediator of cell survival."

reach
"CYLD can suppress the activation of NF-κB or JNK signaling by removing K63-linked polyubiquitin chains from the signaling complex [27–29,40]."

reach
"CYLD negatively regulates the activation of IKK and JNK, and its expression is markedly upregulated under conditions of RANKL induced osteoclastogenesis [XREF_BIBR]."

reach
"The loss of CYLD in both primary T cells and the Jurkat T cell line causes the constitutive activation of Tak1 as well as its downstream targets JNK and IKK."

reach
"CYLD negatively regulates NF-κB, WNT, and JNK signaling, and inactivating mutations can result in aberrant pathway activation, ultimately leading to enhanced cell proliferation, inhibition of apoptosi[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"CYLD also negatively regulates the c-Jun N-terminal kinase (JNK) signaling pathway and mitogen activated protein kinase (MAPK) pathway, which are known to participate in a wide range of cellular processes, including proliferation, differentiation, and apoptosis of cholesteatoma [XREF_BIBR, XREF_BIBR]."

reach
"Expression of a non cleavable form of CYLD inhibited activation of the JNK pathway and expression of AP-1 target genes in a T-cell line, although CYLD silencing only minimally increased JNK activation [XREF_BIBR], possibly because of redundancy with other deubiquitinating enzymes."

reach
"C-Jun N-terminal kinase (JNK) signaling pathway activated by TNF alpha, anti-CD40 antibody, IL-1 beta, and lipopolysaccharide is repressed by CYLD by reducing the activity of MKK7 and JNKK2, which is [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"CYLD, a de-ubiquitinating enzyme, suppresses both the NF-kappaB pathway [XREF_BIBR, XREF_BIBR] and the c-Jun N-terminal kinase pathway [XREF_BIBR - XREF_BIBR]."

reach
"Ubiquitination is subject to negative regulation by deubiquitinases (DUBs) such as CYLD which removes K63-Ub and M1-Ub from target proteins, and thereby negatively regulates NF-κB and JNK pathways (4, 5)."

reach
"Loss of CYLD in T cells leads to constitutive activation of TAK1 and its downstream kinases c-Jun N -terminal kinase (JNK) and IκB kinase β (IKKβ)."

reach
"Depending on the cellular context CYLD has been shown to negatively regulate NF-kappaB and/or JNK signalling pathways resulting in suppression of cell proliferation and survival."

reach
"Conversely, loss of the K63 specific deubiquitinase CYLD causes spontaneous activation of IKK and JNK as well as their upstream kinase Tak1."

reach
"Subsequent studies have demonstrated that CYLD negatively regulates nuclear factor kappa B (NF-kappaB) and c-Jun N-terminal kinase (JNK) pathways, and plays a critical role in immunity, lipid metaboli[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"However, CYLD was also reported to negatively regulate JNK signaling in culture cells ( Reiley et al., 2004 ) and macrophages ( Zhang et al., 2006 )."

reach
"Thus, CYLD could positively or negatively regulate JNK signaling in a cell-type-specific manner.To genetically map the epistasis of dCYLD and dTRAF2 in the Egr-JNK pathway, we examined the genetic int[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"While CYLD negatively regulates JNK activation by diverse stimuli, it exerts an inhibitory effect on NF-kappaB pathway by anti-CD40, LPS, and IL-1beta."

reach
"We show that mesenchymal Cyld contributes to prevent excessive JNK and NF-κB activation in TNF-stimulated naive and arthritic SFs."

reach
"CYLD deletion causes accumulation of constitutively active TAK1, and its downstream kinases JNK and IKK, which results in T cells that become hyper-responsive to TCR stimulation."

reach
"On the contrary, CYLD WT overexpression leads to a diminished JNK activation both in non stimulated and in TNF-alpha-stimulated A-CYLD WT cells (XREF_FIG)."

reach
"CYLD, a tumor suppressor and a target gene of NF-kappaB, negatively regulates NF-kappaB and JNK activation by removing K63 linked polyubiquitin chains from TRAF2 and TRAF6 as well as several other signaling proteins [XREF_BIBR, XREF_BIBR]."

reach
"However, because Cyld deficiency did not cause the activation of ERK, the target of CYLD might be an intermediate signaling factor specifically mediating the activation of JNK and IKKbeta."

reach
"Treatment with MPA also increases the transcription of ubiquitin carboxyl-terminal hydrolase CYLD (log2FC 0.12, padj = 0.04), which is known to suppress the NF-κB, p38MAPK and c-Jun N-terminal kinase (JNK) cascades."